Recruiting
Pulmonary Hypertension Institutional Registry at Hospital Italiano de Buenos Aires
The purpose of this study is to create a registry of patients with Pulmonary Hypertension who received medical care in the Hospital Italiano of Buenos Aires.
ClinicalTrials.gov IDNCT01501838
PhaseNot Applicable
Enrollment200
SponsorHospital Italiano de Buenos Aires
Age17 Years
SexALL
Conditions studied
Hypertension, Pulmonary Arterial
About this study
The purpose of this study is to create a registry of patients with Pulmonary Hypertension who received medical care in the Hospital Italiano of Buenos Aires.
Primary outcomes
- Pulmonary Hypertension prevalence (1 year)
- Pulmonary Hypertension incidence (1 year)
Eligibility information
* Inclusion Criteria:
1. Diagnosed with PAH WHO group 1 (2022 ESC/ESR guidelines criteria) as the presence of a mean pulmonary artery pressure (mPAP) greater than 20 mmHg at rest with pulmonary arterial wedge pressure (PAWP) \>15 mmHg and pulmonary vascular resistance (PVR) \>2 WU, according to the 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.
2. Included in the institutional registry of PAH of Hospital Italiano de Buenos Aires
3. Aged ≥18 years at the index date.
* Exclusion Criteria History of lung transplantation surgery previously the baseline period
Study locations
- Hospital Italiano de Buenos Aires, Buenos Aires, Buenos Aires 1181 Argentina
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.